Page last updated: 2024-08-17

lysergic acid diethylamide and n-methyl-3,4-methylenedioxyamphetamine

lysergic acid diethylamide has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 84 studies

Research

Studies (84)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (5.95)	18.7374
1990's	13 (15.48)	18.2507
2000's	26 (30.95)	29.6817
2010's	16 (19.05)	24.3611
2020's	24 (28.57)	2.80

Authors

Authors	Studies
Frescas, SP; Johnson, MP; Nichols, DE; Oberlender, R	1
Brewster, WK; Johnson, MP; Nichols, DE; Oberlender, R; Riggs, RM	1
Hoffman, AJ; Jacob, P; Nichols, DE; Oberlender, RA; Shulgin, AT	1
Lyttle, T; Montagne, M	1
Lever, JR; Ricaurte, GA; Scheffel, U; Stathis, M	1
Bakalar, JB; Grinspoon, L	1
Heym, J; Jacobs, BL	1
Nichols, DE; Oberlender, R	1
Appel, JB; Callahan, PM	1
Clark, JC; Forrest, AR; Galloway, JH; Marsh, ID; Strachan, GA	1
Brown, ER; Jarvie, DR; Simpson, D	1
Schechter, MD	2
Durst, R; Rebaudengo-Rosca, P	1
Baker, LE; Taylor, MM	1
Barrio Anta, G; de la Fuente de Hoz, L; Rodríguez Arenas, MA; Royuela, L	1
Erdtmann-Vourliotis, M; Höllt, V; Mayer, P; Riechert, U	2
Bogusz, MJ; Krüger, KD; Maier, RD; Miller, ML; Romeril, J; Webb, KS	1
Ghuran, A; Nolan, J	1
Baker, LE; Goodwin, AK	2
Amara, SG; Arttamangkul, S; Bunzow, JR; Darland, T; Grandy, DK; Harrison, LM; Kennedy, JL; Magenis, RE; Olson, SB; Pasumamula, S; Quigley, DI; Sonders, MS; Suchland, KL; Zhang, G	1
Ferrand, I	1
Berry, K; Riordan, M; Rylance, G	1
Fendrich, M; Hubbell, A; Johnson, TP; Wislar, JS	1
Bellis, MA; Bennett, A; Hughes, K; Thomson, R	1
Klein, M; Kramer, F	1
Check, E	1
Cuddy, ML	1
Kennedy, CL; Parks, KA	1
Sessa, B	2
Diamond, GM; Hutlzer, A; Izzard, MC; Kedar, T; Mell, H	1
Galvin, DM; Schlenger, WE; Wu, LT	1
Kelly, BC; Parsons, JT; Wells, BE	1
Firth, AY	1
Baker, LE; Kueh, D	1
Jurgaitiene, D; Targamadze, V	1
Hunt, N; McCambridge, J; Mitcheson, L; Winstock, A	1
Amorosi, DJ; Rabin, RA; Rice, KC; Winter, JC	1
Fantegrossi, WE; Katz, EB; Reissig, CJ; Rice, KC; Winter, JC; Yarosh, HL	1
Fisk, JE; Montgomery, C	1
Dermatis, H; Franklin, J; Galanter, M; Horowitz, A	1
Carbonaro, T; Forster, MJ; Gatch, MB; Rutledge, MA	1
Delucchi, K; Grov, C; Kelly, BC; Parsons, JT; Ramo, DE	1
Nichols, D	1
Cachat, J; Collins, C; Gaikwad, S; Green, J; Grieco, F; Kalueff, AV; Kyzar, EJ; Landsman, S; Noldus, LP; Pham, M; Roth, A; Stewart, AM; Tegelenbosch, R	1
Carbonaro, TM; Forster, MJ; Gatch, MB	1
Airado-Rodríguez, D; Cruces-Blanco, C; García-Campaña, AM	1
Barratt, MJ; Ferris, JA; Winstock, AR	1
Talbert, JJ	1
Brunt, TM; van der Gouwe, D; van der Pol, P; van Laar, M	1
Baker, LE; Berquist, MD	1
Gallinat, J; Hermle, L; Jungaberle, H; Majić, T; Schmidt, TT; Zeuch, A	1
Graydon-Guy, T; Prasad, J; Romeo, JS; Rychert, M; Wilkins, C	1
Bernardo, RA; Chaves, AR; da Silva, LC; Queiroz, MEC; Vaz, BG	1
Nutt, D	1
Borgwardt, S; Duerig, R; Eckert, A; Holze, F; Ley, L; Liechti, ME; Müller, F; Varghese, N; Vizeli, P	1
Carpenter, LL; Kalin, NH; McDonald, WM; Nemeroff, CB; Reiff, CM; Richman, EE; Rodriguez, CI; Widge, AS	1
Abbott, KL; Boothe, DM; Dhanasekaran, M; Flannery, PC; Gill, KS; Pondugula, SR	1
Baker, LE; Herr, KA	1
Borgwardt, S; Dolder, P; Holze, F; Ley, L; Liechti, ME; Müller, F; Soltermann, A; Vizeli, P	1
Aguilar-Valles, A; De Gregorio, D; Gobbi, G; Heifets, BD; Hibicke, M; Mitchell, J; Preller, KH	1
Tullis, P	1
Bates, MLS; Trujillo, KA	1
Gasser, P; Liechti, ME; Oehen, P; Schmid, Y	1
Cusimano, J; Hosanagar, A; Radhakrishnan, R	2
de la Salle, S; Fogg, C; Jahn, ZW; Michaels, TI; Williams, MT	1
Barnett, BS; Parker, SE; Weleff, J	1
Holze, F; Liechti, ME	1
Jones, GM; Nock, MK	1
Erdmann, M; Hase, A; Hasler, G; Limbach, V	1
Andreou, C; Avram, M; Borgwardt, S; Holze, F; Korda, A; Ley, L; Liechti, ME; Müller, F; Rogg, H; Vizeli, P	1
Han, BH; Palamar, JJ; Yang, KH	1
Hasin, DS; Livne, O; Shmulewitz, D; Walsh, C	1
Breeksema, JJ; Kamphuis, J; Kuin, BW; Schoevers, RA; van den Brink, W; Vermetten, E	1
Arias, D; Jones, G; Nock, M	1
Becker, AM; Duthaler, U; Eckert, A; Holze, F; Klaiber, A; Ley, L; Liechti, ME; Straumann, I; Varghese, N; Wey, K	1
Reardon, S	1
Holstein, A; Klumpers, LE; Knowles, R; Mantuani, D; Tagen, M; van Heerden, L	1

Reviews

14 review(s) available for lysergic acid diethylamide and n-methyl-3,4-methylenedioxyamphetamine

Article	Year
Serotonergic mechanisms of hallucinogenic drug effects. Monographs in neural sciences, 1987, Volume: 13 Topics: 3,4-Methylenedioxyamphetamine; Action Potentials; Animals; Brain; Hallucinogens; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Receptors, Serotonin	1987
Recreational drug misuse: issues for the cardiologist. Heart (British Cardiac Society), 2000, Volume: 83, Issue:6 Topics: Adolescent; Adult; Amphetamines; Cannabis; Cardiovascular Diseases; Child; Cocaine; Drug Overdose; Female; Hallucinogens; Heroin; Humans; Lysergic Acid Diethylamide; Male; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Psilocybin; Substance-Related Disorders	2000
Poisoning in children 5: rare and dangerous poisons. Archives of disease in childhood, 2002, Volume: 87, Issue:5 Topics: 2-Propanol; Adrenergic beta-Antagonists; Carbon Monoxide Poisoning; Child; Cocaine; Cyanides; Digoxin; Ethylene Glycol; Humans; Hypoglycemic Agents; Insecticides; Isoniazid; Lysergic Acid Diethylamide; Methanol; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Organophosphorus Compounds; Poisoning	2002
Rave drugs: pharmacological considerations. AANA journal, 2004, Volume: 72, Issue:1 Topics: Adolescent; Adult; Anesthesia; Dancing; Designer Drugs; Emergency Treatment; Flunitrazepam; Hallucinogens; Humans; Hydroxybutyrates; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Substance-Related Disorders	2004
Common drugs of abuse--Part II. The Journal of practical nursing, 2004,Spring, Volume: 54, Issue:1 Topics: 4-Butyrolactone; Catha; Designer Drugs; Dibenzothiazepines; Diterpenes; Diterpenes, Clerodane; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug and Narcotic Control; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Phenylpropanolamine; Piperazines; Psilocybin; Quetiapine Fumarate; Sodium Oxybate; Substance-Related Disorders; United States	2004
[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges]. Fortschritte der Neurologie-Psychiatrie, 2017, Volume: 85, Issue:7 Topics: Combined Modality Therapy; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychotherapy; Serotonin Agents; Treatment Outcome	2017
Psychedelic drugs-a new era in psychiatry? . Dialogues in clinical neuroscience, 2019, Volume: 21, Issue:2 Topics: Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychiatry	2019
Psychedelics and Psychedelic-Assisted Psychotherapy. The American journal of psychiatry, 2020, 05-01, Volume: 177, Issue:5 Topics: Evidence-Based Practice; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychotherapy	2020
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2021, 02-03, Volume: 41, Issue:5 Topics: Animals; Brain; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Mental Disorders; Mental Health; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Randomized Controlled Trials as Topic	2021
Use and abuse of dissociative and psychedelic drugs in adolescence. Pharmacology, biochemistry, and behavior, 2021, Volume: 203 Topics: Adolescent; Adult; Age Factors; Animals; Dextromethorphan; Female; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Psilocybin; Risk-Taking; Substance-Related Disorders	2021
Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1: Psychopharmacology and Neurobiological Effects. The Journal of clinical psychiatry, 2021, 02-23, Volume: 82, Issue:2 Topics: Banisteriopsis; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychopharmacology	2021
Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2: Review of the Evidence. The Journal of clinical psychiatry, 2021, 02-23, Volume: 82, Issue:3 Topics: Banisteriopsis; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin	2021
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:10 Topics: Banisteriopsis; Hallucinogens; Headache; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin	2022
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease. Journal of psychopharmacology (Oxford, England), 2023, Volume: 37, Issue:9 Topics: Hallucinogens; Heart Valve Diseases; Humans; Lysergic Acid Diethylamide; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Serotonin	2023

Trials

5 trial(s) available for lysergic acid diethylamide and n-methyl-3,4-methylenedioxyamphetamine

Article	Year
Evidence for selective executive function deficits in ecstasy/polydrug users. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:1 Topics: Adult; Amphetamine-Related Disorders; Cannabis; Cocaine; Cognition; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Problem Solving; Tablets	2009
MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2021, Volume: 46, Issue:3 Topics: Double-Blind Method; Hallucinogens; Humans; Lysergic Acid Diethylamide; Magnetic Resonance Imaging; N-Methyl-3,4-methylenedioxyamphetamine	2021
Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies. Experimental and clinical psychopharmacology, 2021, Volume: 29, Issue:5 Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychotherapy	2021
United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020. The International journal on drug policy, 2022, Volume: 99 Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; National Institutes of Health (U.S.); Psilocybin; United States	2022
Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023, Volume: 48, Issue:13 Topics: Cross-Over Studies; Double-Blind Method; Female; Hallucinogens; Healthy Volunteers; Humans; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine	2023

Other Studies

65 other study(ies) available for lysergic acid diethylamide and n-methyl-3,4-methylenedioxyamphetamine

Article	Year
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA). Journal of medicinal chemistry, 1991, Volume: 34, Issue:5 Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Brain; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Phenethylamines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Stereoisomerism; Structure-Activity Relationship	1991
Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA). Journal of medicinal chemistry, 1990, Volume: 33, Issue:2 Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Behavior, Animal; Catecholamines; Cerebral Cortex; Hippocampus; Indans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Piperidines; Psychotropic Drugs; Rats; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes	1990
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class. Journal of medicinal chemistry, 1986, Volume: 29, Issue:10 Topics: Adult; Animals; Butylamines; Dioxoles; Discrimination Learning; Female; Generalization, Stimulus; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psychotropic Drugs; Rats; Rats, Inbred Strains; Structure-Activity Relationship	1986
Drugs, music, and ideology: a social pharmacological interpretation of the Acid House Movement. The International journal of the addictions, 1992, Volume: 27, Issue:10 Topics: 3,4-Methylenedioxyamphetamine; Humans; Leisure Activities; Lysergic Acid Diethylamide; Mass Media; Music; N-Methyl-3,4-methylenedioxyamphetamine; Social Behavior; Substance-Related Disorders; United Kingdom	1992
Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors. Neuropharmacology, 1992, Volume: 31, Issue:9 Topics: 3,4-Methylenedioxyamphetamine; Animals; Autoradiography; Brain; Brain Chemistry; Down-Regulation; Half-Life; Iodine Radioisotopes; Kinetics; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin	1992
Can drugs be used to enhance the psychotherapeutic process? American journal of psychotherapy, 1986, Volume: 40, Issue:3 Topics: 3,4-Methylenedioxyamphetamine; Adult; Awareness; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mental Disorders; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Psychotherapy; Self Disclosure	1986
Drug discrimination studies with MDMA and amphetamine. Psychopharmacology, 1988, Volume: 95, Issue:1 Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Stereoisomerism; Structure-Activity Relationship	1988
Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline. The Journal of pharmacology and experimental therapeutics, 1988, Volume: 246, Issue:3 Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Hallucinogens; Lysergic Acid Diethylamide; Male; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains	1988
A fatal overdose with 3,4-methylenedioxyamphetamine derivatives. Forensic science international, 1994, Volume: 64, Issue:1 Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamines; Cannabinoids; Cannabis; Designer Drugs; Drug Overdose; Fatal Outcome; Humans; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Postmortem Changes; Substance-Related Disorders	1994
Use of drugs at 'raves'. Scottish medical journal, 1995, Volume: 40, Issue:6 Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Catha; Central Nervous System Stimulants; Dancing; Designer Drugs; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Plant Extracts; Scotland; Substance-Related Disorders; Surveys and Questionnaires	1995
Drug-drug discrimination: stimulus properties of drugs of abuse upon a serotonergic-dopaminergic continuum. Pharmacology, biochemistry, and behavior, 1997, Volume: 56, Issue:1 Topics: Amphetamine; Animals; Discrimination, Psychological; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Generalization, Stimulus; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norfenfluramine; Propiophenones; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Substance-Related Disorders; Tetrahydronaphthalenes; Time Factors	1997
[Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult]. Harefuah, 1997, May-01, Volume: 132, Issue:9 Topics: Adult; Alcoholism; Attention Deficit Disorder with Hyperactivity; Cannabis; Central Nervous System Stimulants; Female; Humans; Lysergic Acid Diethylamide; Marijuana Abuse; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders	1997
Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination. Pharmacology, biochemistry, and behavior, 1997, Volume: 57, Issue:4 Topics: 3,4-Methylenedioxyamphetamine; Animals; Cocaine; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Food; Generalization, Psychological; Hallucinogens; Lysergic Acid Diethylamide; Male; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Stereoisomerism	1997
[Emergencies associated with the consumption of designer drugs, hallucinogens and amphetamines treated at 15 Spanish hospitals in 1994. Work Group on the Study of Emergencies due to Psychostimulants]. Revista clinica espanola, 1997, Volume: 197, Issue:12 Topics: Adolescent; Adult; Amphetamine-Related Disorders; Child; Cocaine-Related Disorders; Designer Drugs; Emergencies; Emergency Service, Hospital; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substance-Induced; Spain; Substance-Related Disorders	1997
'Candyflipping': synergistic discriminative effect of LSD and MDMA. European journal of pharmacology, 1998, Jan-12, Volume: 341, Issue:2-3 Topics: Animals; Behavior, Animal; Discrimination Learning; Drug Synergism; Hallucinogens; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Serotonin Agents	1998
Acute injection of drugs with low addictive potential (delta(9)-tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine). Brain research. Molecular brain research, 1999, Aug-25, Volume: 71, Issue:2 Topics: Animals; Cocaine; Dronabinol; Hallucinogens; Illicit Drugs; In Situ Hybridization; Limbic System; Lysergic Acid Diethylamide; Male; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar	1999
Poor reproducibility of in-source collisional atmospheric pressure ionization mass spectra of toxicologically relevant drugs. Journal of chromatography. A, 1999, Jun-04, Volume: 844, Issue:1-2 Topics: Atmospheric Pressure; Hallucinogens; Lysergic Acid Diethylamide; Mass Spectrometry; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Reproducibility of Results; Toxicology	1999
Prior experience of morphine application alters the c-fos response to MDMA ('ecstasy') and cocaine in the rat striatum. Brain research. Molecular brain research, 2000, Apr-14, Volume: 77, Issue:1 Topics: Animals; Cocaine; Corpus Striatum; Gene Expression Regulation; Genes, fos; Lysergic Acid Diethylamide; Male; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Transcription, Genetic	2000
A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats. Experimental and clinical psychopharmacology, 2000, Volume: 8, Issue:3 Topics: Adrenergic Uptake Inhibitors; Animals; Cocaine; Cues; Dextroamphetamine; Discrimination, Psychological; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fenfluramine; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists	2000
Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Molecular pharmacology, 2001, Volume: 60, Issue:6 Topics: Amino Acid Sequence; Amphetamine; Animals; Catecholamines; Chromosome Mapping; Chromosomes, Human, Pair 6; Cloning, Molecular; Dopamine Agents; Humans; Lysergic Acid Diethylamide; Molecular Sequence Data; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Agents; Rats; Receptors, Biogenic Amine; Sequence Homology, Amino Acid; Serotonin Agents; Subcellular Fractions; Tumor Cells, Cultured	2001
[Current drugs. New clinical problems]. Bulletin de l'Academie nationale de medecine, 2002, Volume: 186, Issue:2 Topics: Hallucinogens; Humans; Illicit Drugs; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine	2002
An analysis of the utility of differential outcome procedures in drug discrimination research. Behavioural pharmacology, 2002, Volume: 13, Issue:4 Topics: Animals; Central Nervous System Stimulants; Conditioning, Operant; Dextroamphetamine; Discrimination, Psychological; Hallucinogens; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Reinforcement Schedule	2002
A contextual profile of club drug use among adults in Chicago. Addiction (Abingdon, England), 2003, Volume: 98, Issue:12 Topics: Adolescent; Adult; Central Nervous System Stimulants; Chicago; Ethnicity; Female; Hallucinogens; Humans; Illicit Drugs; Lysergic Acid Diethylamide; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Risk Factors; Sex Factors; Sexual Behavior; Social Behavior; Substance-Related Disorders	2003
The role of an international nightlife resort in the proliferation of recreational drugs. Addiction (Abingdon, England), 2003, Volume: 98, Issue:12 Topics: Adolescent; Adult; Alcohol Drinking; Cocaine-Related Disorders; Cross-Sectional Studies; Female; Hallucinogens; Holidays; Humans; Illicit Drugs; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Spain; Substance-Related Disorders; Surveys and Questionnaires; Transients and Migrants; United Kingdom	2003
Psychedelic drugs: the ups and downs of ecstasy. Nature, 2004, May-13, Volume: 429, Issue:6988 Topics: Agaricales; Animals; Anxiety; Brain; Cactaceae; Controlled Clinical Trials as Topic; Female; Hallucinogens; History, 20th Century; History, 21st Century; Humans; Lysergic Acid Diethylamide; Medicine, Traditional; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Phytotherapy; Pilot Projects; Psilocybin; Psychotherapy; Stress Disorders, Post-Traumatic	2004
Club drugs: reasons for and consequences of use. Journal of psychoactive drugs, 2004, Volume: 36, Issue:3 Topics: Adolescent; Adult; Central Nervous System Stimulants; Dextromethorphan; Female; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Interviews as Topic; Ketamine; Life Style; Lysergic Acid Diethylamide; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Oxybate; Substance-Related Disorders; United States	2004
Can psychedelics have a role in psychiatry once again? The British journal of psychiatry : the journal of mental science, 2005, Volume: 186 Topics: Hallucinogens; History, 20th Century; Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Psychiatry; Psychoses, Substance-Induced	2005
Psychological symptoms and drug use severity among Israeli adolescents presenting for outpatient drug abuse treatment. Journal of adolescence, 2005, Volume: 28, Issue:4 Topics: Adolescent; Ambulatory Care; Attention Deficit and Disruptive Behavior Disorders; Depression; Female; Hallucinogens; Humans; Israel; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Patient Acceptance of Health Care; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Substance-Related Disorders	2005
Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths. Drug and alcohol dependence, 2006, Sep-01, Volume: 84, Issue:1 Topics: Adolescent; Adult; Age of Onset; Data Collection; Demography; Female; Flunitrazepam; Humans; Incidence; Ketamine; Lysergic Acid Diethylamide; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Sodium Oxybate; Substance-Related Disorders	2006
Differences in club drug use between heterosexual and lesbian/bisexual females. Addictive behaviors, 2006, Volume: 31, Issue:12 Topics: Adolescent; Adult; Age Factors; Amphetamine-Related Disorders; Bisexuality; Cocaine-Related Disorders; Female; Gender Identity; Homosexuality, Female; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; New York City; Sexuality; Sodium Oxybate; Substance-Related Disorders	2006
Editorial: ocular effects of criminal drug use. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2006, Volume: 41, Issue:2 Topics: Cannabis; Cocaine; Eye Diseases; Heroin; Humans; Illicit Drugs; Lysergic Acid Diethylamide; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine	2006
Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine. Psychopharmacology, 2007, Volume: 189, Issue:4 Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Stimulus; Hallucinogens; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Time Factors	2007
[Relations between usage of marihuana and other drugs among teenagers]. Medicina (Kaunas, Lithuania), 2006, Volume: 42, Issue:10 Topics: Adolescent; Adolescent Behavior; Age Factors; Alcohol Drinking; Amphetamine-Related Disorders; Attitude to Health; Data Collection; Data Interpretation, Statistical; Female; Hallucinogens; Humans; Illicit Drugs; Lithuania; Lysergic Acid Diethylamide; Male; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Sex Factors; Smoking; Substance Abuse, Intravenous; Substance-Related Disorders; Surveys and Questionnaires	2006
5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. European addiction research, 2007, Volume: 13, Issue:1 Topics: Adult; Cross-Sectional Studies; Female; Hallucinogens; Humans; Incidence; Ketamine; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Psilocybin; Substance-Related Disorders; United Kingdom	2007
Psilocybin-induced stimulus control in the rat. Pharmacology, biochemistry, and behavior, 2007, Volume: 87, Issue:4 Topics: Animals; Conditioning, Operant; Data Interpretation, Statistical; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Stimulus; Hallucinogens; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Psilocybin; Rats; Rats, Inbred F344; Reinforcement Schedule	2007
Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents. Pharmacology, biochemistry, and behavior, 2008, Volume: 88, Issue:3 Topics: Animals; Data Interpretation, Statistical; Discrimination Learning; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Lysergic Acid Diethylamide; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Piperidines; Psilocybin; Pyridines; Rats; Rats, Inbred F344; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Tryptamines	2008
Use of and attitudes toward club drugs by medical students. Journal of addictive diseases, 2008, Volume: 27, Issue:4 Topics: Adult; Anesthetics, Intravenous; Anti-Anxiety Agents; Central Nervous System Stimulants; Dextromethorphan; Excitatory Amino Acid Antagonists; Female; Flunitrazepam; Hallucinogens; Health Knowledge, Attitudes, Practice; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Male; Methamphetamine; Midwestern United States; N-Methyl-3,4-methylenedioxyamphetamine; Sex Distribution; Sodium Oxybate; Students, Medical; Substance-Related Disorders; Surveys and Questionnaires; Young Adult	2008
Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats. Psychopharmacology, 2009, Volume: 204, Issue:4 Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Lysergic Acid Diethylamide; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Rats; Rats, Sprague-Dawley	2009
Typology of club drug use among young adults recruited using time-space sampling. Drug and alcohol dependence, 2010, Mar-01, Volume: 107, Issue:2-3 Topics: Adjuvants, Anesthesia; Adolescent; Adult; Cocaine; Dopamine Uptake Inhibitors; Drug Users; Excitatory Amino Acid Antagonists; Female; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; New York City; Prevalence; Risk Factors; Sex Factors; Sexual Behavior; Social Environment; Sodium Oxybate; Space-Time Clustering; Substance-Related Disorders; Young Adult	2010
Legal highs: the dark side of medicinal chemistry. Nature, 2011, Jan-06, Volume: 469, Issue:7328 Topics: Amphetamines; Animals; Depression; Designer Drugs; Drug Design; Electronic Mail; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease; Research Personnel; Schizophrenia; Substance-Related Disorders	2011
Automated high-throughput neurophenotyping of zebrafish social behavior. Journal of neuroscience methods, 2012, Sep-30, Volume: 210, Issue:2 Topics: Analysis of Variance; Animals; Behavior, Animal; Electronic Data Processing; Hallucinogens; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Phenotype; Social Behavior; Time Factors; Video Recording; Zebrafish	2012
Discriminative stimulus effects of N,N-diisopropyltryptamine. Psychopharmacology, 2013, Volume: 226, Issue:2 Topics: Animals; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Hallucinogens; Lysergic Acid Diethylamide; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Tryptamines	2013
Dispersive liquid-liquid microextraction prior to field-amplified sample injection for the sensitive analysis of 3,4-methylenedioxymethamphetamine, phencyclidine and lysergic acid diethylamide by capillary electrophoresis in human urine. Journal of chromatography. A, 2012, Dec-07, Volume: 1267 Topics: Electrophoresis, Capillary; Humans; Liquid Phase Microextraction; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine	2012
Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States. Addiction (Abingdon, England), 2014, Volume: 109, Issue:5 Topics: Adult; Australia; Cannabis; Data Collection; Drug Trafficking; Female; Humans; Illicit Drugs; Internet; Logistic Models; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; United Kingdom; United States; Young Adult	2014
Club drugs: coming to a patient near you. The Nurse practitioner, 2014, Mar-13, Volume: 39, Issue:3 Topics: Adolescent; Adult; Female; Flunitrazepam; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nurse Practitioners; Primary Care Nursing; Sodium Oxybate; Substance-Related Disorders; Young Adult	2014
End the drug war's research bans. Scientific American, 2014, Volume: 310, Issue:2 Topics: Humans; Legislation, Drug; Lysergic Acid Diethylamide; Medical Marijuana; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine	2014
Turn on and tune in to evidence-based psychedelic research. The lancet. Psychiatry, 2015, Volume: 2, Issue:1 Topics: Anxiety Disorders; Biomedical Research; Chemotherapy, Adjuvant; Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Psychotherapy; Stress Disorders, Post-Traumatic	2015
Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands. Addiction (Abingdon, England), 2017, Volume: 112, Issue:4 Topics: Amphetamine; Amphetamines; Benzofurans; Central Nervous System Stimulants; Cocaine; Cyclohexanones; Cyclohexylamines; Dimethoxyphenylethylamine; Drug Contamination; Drug Costs; Drug Trafficking; Hallucinogens; Humans; Illicit Drugs; Internet; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Propylamines	2017
Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats. Behavioural pharmacology, 2017, Volume: 28, Issue:5 Topics: Animals; Benzodioxoles; Cocaine; Dextroamphetamine; Discrimination Learning; Dopamine; Dopamine Agents; Fenfluramine; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Synthetic Cathinone	2017
Club Drugs: What You Should Know. American family physician, 2018, 07-15, Volume: 98, Issue:2 Topics: Anesthetics, Dissociative; Anti-Anxiety Agents; Central Nervous System Stimulants; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine	2018
Determinants of high availability of methamphetamine, cannabis, LSD and ecstasy in New Zealand: Are drug dealers promoting methamphetamine rather than cannabis? The International journal on drug policy, 2018, Volume: 61 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cannabinoids; Cannabis; Female; Humans; Illicit Drugs; Lysergic Acid Diethylamide; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; New Zealand; Substance-Related Disorders; Surveys and Questionnaires; Young Adult	2018
Lab-made solid phase microextraction phases for off line extraction and direct mass spectrometry analysis: Evaluating the extraction parameters. Journal of chromatography. A, 2019, Oct-11, Volume: 1603 Topics: Cocaine; Healthy Volunteers; Humans; Jatropha; Lysergic Acid Diethylamide; Methamphetamine; Molecular Imprinting; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Phorbol Esters; Plant Extracts; Polymers; Pyrroles; Saliva; Solid Phase Microextraction; Spectrometry, Mass, Electrospray Ionization; Stainless Steel; Urinalysis	2019
Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020, Volume: 45, Issue:3 Topics: Adult; Affect; Central Nervous System Stimulants; Consciousness; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Female; Hallucinogens; Healthy Volunteers; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Retrospective Studies; Time Factors	2020
Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances. ACS chemical neuroscience, 2020, 05-20, Volume: 11, Issue:10 Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Substance-Related Disorders	2020
Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats. Behavioural pharmacology, 2020, Volume: 31, Issue:8 Topics: Animals; Central Nervous System Stimulants; Discrimination Learning; Dose-Response Relationship, Drug; Female; Hallucinogens; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Serotonin; Serotonin Antagonists	2020
How ecstasy and psilocybin are shaking up psychiatry. Nature, 2021, Volume: 589, Issue:7843 Topics: Animals; Certification; Clinical Trials as Topic; Depression; Depressive Disorder, Treatment-Resistant; Drug Prescriptions; Efficiency; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Neuronal Plasticity; Niacin; Psilocybin; Psychiatry; Psychotherapy; Rumination, Cognitive; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic	2021
Acute subjective effects in LSD- and MDMA-assisted psychotherapy. Journal of psychopharmacology (Oxford, England), 2021, Volume: 35, Issue:4 Topics: Adult; Combined Modality Therapy; Compassionate Use Trials; Consciousness Disorders; Depressive Disorder, Major; Drug Monitoring; Female; Hallucinogens; Healthy Volunteers; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Mysticism; N-Methyl-3,4-methylenedioxyamphetamine; Psychotherapy; Stress Disorders, Post-Traumatic; Treatment Outcome	2021
Dosing Psychedelics and MDMA. Current topics in behavioral neurosciences, 2022, Volume: 56 Topics: Hallucinogens; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Psilocybin	2022
MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults. Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:1 Topics: Adolescent; Adult; Aged; Female; Hallucinogens; Health Surveys; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Stress, Psychological; Substance-Related Disorders; Suicidal Ideation; United States; Young Adult	2022
Analysis of recreational psychedelic substance use experiences classified by substance. Psychopharmacology, 2022, Volume: 239, Issue:2 Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Substance-Related Disorders	2022
Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration. Biological psychiatry. Cognitive neuroscience and neuroimaging, 2022, Volume: 7, Issue:9 Topics: Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Hallucinogens; Humans; Lysergic Acid; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine	2022
Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults. Addictive behaviors, 2022, Volume: 132 Topics: Adult; Depression; Depressive Disorder, Major; Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psychological Distress; Suicidal Ideation; Suicide	2022
Adolescent and adult time trends in US hallucinogen use, 2002-19: any use, and use of ecstasy, LSD and PCP. Addiction (Abingdon, England), 2022, Volume: 117, Issue:12 Topics: Adolescent; Adult; Cross-Sectional Studies; Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; United States; Young Adult	2022
Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents. Scientific reports, 2022, 12-19, Volume: 12, Issue:1 Topics: Adolescent; Child; Cross-Sectional Studies; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Suicidal Ideation	2022
How psychedelic drugs achieve their potent health benefits. Nature, 2023, Volume: 618, Issue:7966 Topics: Animals; Hallucinogens; Health; Humans; Lysergic Acid Diethylamide; Mice; N-Methyl-3,4-methylenedioxyamphetamine	2023